Seongho Ryu

4.4k citations
58 papers · 3.6k · 1 hit paper · h-index 23

Impact in

  • Oncology top 2%
    • Cancer Cells and Metastasis
    • Cancer Immunotherapy and Biomarkers
    • MicroRNA in disease regulation

Papers in

    • MicroRNA in disease regulation 11
    • Immunotherapy and Immune Responses 6
    • Immune cells in cancer 4
    • T-cell and B-cell Immunology 3

Seongho Ryu

54 papers receiving 3.6k citations

Seongho Ryu's Hit Papers

Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance 2015 · 1.5k citations
1.5k0+3+7Years since publication5001k1.5k

Peers

Seongho Ryu
Comparison fields: 5 of 103
  • Oncology 1.2k
  • Cancer Research 594
  • Immunology 366
  • Molecular Biology 1.1k
  • Pharmacology 208
Replace Sarah Schwitalla with:
Sarah Schwitalla Germany
Toby James Phesse Australia
Ramona Graves‐Deal United States
Randal J. May United States
Seong‐Jin Kim South Korea
Alexandra Eichten United States
Debanjan Dhar United States
Abdel‐Majid Khatib France
Stacy Wister Blain United States
Bram De Craene Belgium
Seongho Ryu relative to Sarah Schwitalla Germany Sarah Schwitalla's profile →
Citations per field
00.5×1.5×1.8×
Sarah Schwitalla · 1×
Citations per year

Countries citing papers authored by Seongho Ryu

Since Specialization
Citations

This map shows the geographic impact of Seongho Ryu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seongho Ryu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seongho Ryu more than expected).

Fields of papers citing papers by Seongho Ryu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seongho Ryu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seongho Ryu. The network helps show where Seongho Ryu may publish in the future.

Co-authors

The 25 scholars most cited alongside Seongho Ryu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Seongho Ryu Line = papers co-authored together Seongho Ryu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance
Hit paper breakdown →
20151518
2 2012257
3 2002245
4 2015145
5 2013133
6 2013117
7 2020103
8 200197
9 201689
10 201986
11 202085
12 201971
13 201569
14 201951
15 202047
16 202043
17 202042
18 201237
19 202235
20 201830

About Seongho Ryu

Seongho Ryu is a scholar working on Cancer Research, Immunology, Molecular Biology, Oncology and Epidemiology, having authored 58 papers that have together received 3.6k indexed citations. Recurring topics across this work include Extracellular vesicles in disease (15 papers), MicroRNA in disease regulation (11 papers), Immunotherapy and Immune Responses (6 papers), Cancer Cells and Metastasis (5 papers), Immune cells in cancer (4 papers), T-cell and B-cell Immunology (3 papers), Genomics and Phylogenetic Studies (3 papers) and Cannabis and Cannabinoid Research (2 papers). The work is most often cited by research in Oncology (1.2k citations), Cancer Research (594 citations), Immunology (366 citations), Molecular Biology (1.1k citations) and Pharmacology (208 citations). Seongho Ryu has collaborated with scholars based in South Korea, United States and Thailand. Frequent co-authors include Hyejin Choi, Vivek Mittal, Dingcheng Gao, Linda T. Vahdat, Nasser Khaled Altorki, Sharrell B. Lee, Anna Durrans, Fuhai Li, Jianting Sheng and Tina El Rayes. Their work appears in journals such as Cell Reports, PLoS ONE, Cells, Vaccine and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact